Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any hypotrichosis in which the cause of the disease is a mutation in the LIPH gene.
Features include always present findings: Sparse body hair, Sparse eyebrow, Sparse hair, and Sparse scalp hair and others; and sometimes findings: Woolly hair. 13 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 2 | Abnormal nail morphology, Abnormality of the skin |
LIPH encodes lipase H (451 aa). Hydrolyzes specifically phosphatidic acid (PA) to produce 2-acyl lysophosphatidic acid (LPA; a potent bioactive lipid mediator) and fatty acid. Highest expression in Stomach (28.5 TPM) and Minor Salivary Gland (19.9 TPM).
Hypotrichosis 7 is associated with mutations in the LIPH gene on chromosome 3.
The LIPH protein participates in LIPH, I hydrolyse PA to 2-acyl LPA and Trunk bipotent pancreatic progenitor cell produces pancreatic ductal cell pathways.
LIPH is classified as a druggable target (Druggable Genome, Lipase, and Phospholipase categories) with score 0.0.
Genetic testing for LIPH is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 7 always present features.
No clinical trials have been registered for hypotrichosis 7.
31 publications have been identified in PubMed for hypotrichosis 7. Research spans Review / Meta-Analysis (26%), Basic Science / Preclinical (19%), and Epidemiology / Natural History (19%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 8 | 26% |
Laboratory research | 6 | 19% |
Disease patterns and progression | 6 | 19% |
Other research | 5 | 16% |
Patient case studies | 5 | 16% |
Clinical study results | 1 | 3% |
Mao G (2026). [PMID: 41703066](https://pubmed.ncbi.nlm.nih.gov/41703066/). *Aesthetic Plast Surg*. [Basic Science / Preclinical]
Behrangi E (2026). [PMID: 41987228](https://pubmed.ncbi.nlm.nih.gov/41987228/). *Stem Cell Res Ther*. [Review / Meta-Analysis]
Alwunais K (2026). [PMID: 40457931](https://pubmed.ncbi.nlm.nih.gov/40457931/). *Dermatol Reports*. [Case Report / Case Series]
Gupta P (2026). [PMID: 39912188](https://pubmed.ncbi.nlm.nih.gov/39912188/). *Indian J Dermatol Venereol Leprol*. [Other]
van Hensbergen I (2026). [PMID: 41705568](https://pubmed.ncbi.nlm.nih.gov/41705568/). *Vet Dermatol*. [Basic Science / Preclinical]
Kim YN (2026). [PMID: 41761855](https://pubmed.ncbi.nlm.nih.gov/41761855/). *ChemistryOpen*. [Basic Science / Preclinical]
Shimomura Y (2025). [PMID: 37407443](https://pubmed.ncbi.nlm.nih.gov/37407443/). *Keio J Med*. [Review / Meta-Analysis]
Järvinen A (2025). [PMID: 40551423](https://pubmed.ncbi.nlm.nih.gov/40551423/). *Acta Derm Venereol*. [Epidemiology / Natural History]
Liu RH (2025). [PMID: 39179656](https://pubmed.ncbi.nlm.nih.gov/39179656/). *Aesthetic Plast Surg*. [Epidemiology / Natural History]
Alotaibi HM (2025). [PMID: 40153034](https://pubmed.ncbi.nlm.nih.gov/40153034/). *Arch Dermatol Res*. [Epidemiology / Natural History]
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 8:02 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center